The latest closing stock price for C4 Therapeutics as of March 28, 2025 is 1.75.
An investor who bought $1,000 worth of C4 Therapeutics stock at the IPO in 2020 would have $-931 today, roughly -1 times their original investment - a -48.81% compound annual growth rate over 4 years.
The all-time high C4 Therapeutics stock closing price was 50.50 on September 23, 2021.
The C4 Therapeutics 52-week high stock price is 8.29, which is 373.7% above the current share price.
The C4 Therapeutics 52-week low stock price is 1.74, which is 0.6% below the current share price.
The average C4 Therapeutics stock price for the last 52 weeks is 5.03.
An investor who bought $1,000 worth of C4 Therapeutics stock at the IPO in 2020 would have $-931 today, roughly -1 times their original investment - a -48.81% compound annual growth rate over 4 years.
The all-time high C4 Therapeutics stock closing price was 50.50 on September 23, 2021.
The C4 Therapeutics 52-week high stock price is 8.29, which is 373.7% above the current share price.
The C4 Therapeutics 52-week low stock price is 1.74, which is 0.6% below the current share price.
The average C4 Therapeutics stock price for the last 52 weeks is 5.03.